Europe Today
Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod
French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ulcerative colitis treatment.
This story was reported by Latest News From Euronews | Euronews RSS. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Latest News From Euronews | Euronews RSS →